FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)

View source ↗

Summary

The FDA approved Apotex Corp's supplemental application for a generic omeprazole product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Nsaid-induced Gastroduodenal Ulcers
• Pathological Hypersecretory States
• Peptic Ulcer Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• omeprazole (generic) (omeprazole)

Snippet

SUPPL AP for OMEPRAZOLE (OMEPRAZOLE)